Search Count: 16
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2024-10-09 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1A4P, SO4, ACT, CL, EDO, GOL, PGE |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2024-10-09 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, ACT, A1A4O, SO4, CL, GOL, EDO, LDA |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.38 Å Release Date: 2024-10-09 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1A4N, SO4, ACT, CL, EDO, PGE |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2024-10-09 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1A4M, SO4, ACT, GOL, CL, PGE, EDO |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2024-07-03 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, GOL, ACT, A1AQM, SO4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2024-07-03 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1AQK, ACT, SO4, CL, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2024-07-03 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1AQL, SO4, CL, GOL, ACT |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2024-04-03 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1AA2, ACT, SO4, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2024-04-03 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: FMN, ORO, A1AA1, SO4, ACT, CL |
![]() |
Structure Of Hepatitis B Virus Capsid Y132A Mutant In Complex With Compound 24
Organism: Hepatitis b virus
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2023-04-12 Classification: VIRAL PROTEIN/INHIBITOR Ligands: CL, ZMH |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2022-08-17 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: FMN, ORO, T6L, ACT, GOL, SO4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-08-17 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: FMN, ORO, T78, SO4, ACT, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-08-17 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: FMN, ORO, TMK, ACT, GOL, SO4 |
![]() |
Crystal Structure Of Hbv Capsid Y132A Mutant In Complex With N-(3-Chloro-4-Fluorophenyl)-3-Phenyl-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridine-5-Carboxamide At 2.65A Resolution
Organism: Hepatitis b virus genotype d subtype adw (isolate united kingdom/adyw/1979)
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2021-07-28 Classification: VIRAL PROTEIN Ligands: VXJ, IPA |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2020-10-21 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, VU7, ACT, SO4, GOL, PGE |
![]() |
Method: SOLUTION NMR
Release Date: 2002-02-20 Classification: glycoprotein, immune system Ligands: A2G |